NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. reminds investors that the Firm is investigating potential claims on behalf of Envision Healthcare Corporation (NYSE: EVHC) stockholders concerning the proposed acquisition of the company by Kohlberg Kravis Roberts & Co. (KKR & Co.), a private equity fund.
Our investigation concerns whether Envision’s board of directors failed to adequately shop the Company and obtain the best possible value for its stockholders before entering into a definitive agreement with KKR & Co. Under the terms of the agreement, Envision stockholders will receive $46.00 per share in cash for each Envision share that they own.
If you own Envision shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of Envision Healthcare Corporation, please go to https://bespc.com/envisionhealthcare/. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.